Premium
VNS therapy in clinical practice in children with refractory epilepsy[Note 1. Presented at 23rd International Epilepsy Convention in Prague in ...]
Author(s) -
Nagarajan L.,
Walsh P.,
Gregory P.,
Lee M.
Publication year - 2002
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1034/j.1600-0404.2002.00129.x
Subject(s) - vagus nerve stimulation , tolerability , epilepsy , medicine , adverse effect , anesthesia , clinical practice , refractory (planetary science) , vagus nerve , quality of life (healthcare) , pediatrics , stimulation , physical therapy , psychiatry , physics , nursing , astrobiology
Objectives – To study the efficacy, tolerability and safety of the vagus nerve stimulation (VNS) therapy in clinical practice, in 16 children and adolescents with refractory epilepsy. Methodology – We assessed the efficacy of VNS therapy, retrospectively by comparing seizure frequency, duration and severity at the time of most recent follow up (av: 24.9 months) to that in the 4 weeks prior to VNS surgery. Changes in quality of life, sleep and behaviour at last review was compared with that prior to VNS. Adverse effects elicited by specific questioning, spontaneous reporting and clinical examination are described. Results – Vagus nerve stimulation resulted in a >50% reduction in seizure frequency in 62.5% of children with 25% achieving a >90% reduction. Vagus nerve stimulation was well tolerated in all but one of our cohort, with no serious side‐effects. Conclusion – Our results support its role as one of the options in intractable childhood epilepsy.